Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Irvine Pharmaceutical Services | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Irvine Pharmaceutical Services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Aryo Nikopour has been named vice president of scientific and technical services, and Greg McParland has been named chief operating officer at Irvine Pharmaceutical Services. These changes were made to accommodate the company’s growth, as well as the anticipated launch of its new subsidiary, Avrio Biopharmaceuticals, in January 2009.
   
Mr. Nikopour has spent five years at Irvine and has more than 20 years of experience in the pharmaceutical industry. His previous positions — at organizations such as PPD, Alpharma (Actavis), Solvay Pharmaceuticals and Solvay Animal Health — have helped develop his expertise in a range of areas, including chromatographic method development and validation, extractables/leachables studies, and implementation of new technologies and capabilities such as inhalation/nasal, biopharmaceutical and structural chemistry. He also has experience in scientific staff management, quality control, stability testing and regulatory requirements.
   
Mr. McParland has more than 30 years of experience in the pharmaceutical and chemical industries. Prior to joining the company, he was chief executive officer of Girindus America, Inc., a member of Solvay Organics, where he lead the company through the transition to become a commercial operation focused on small molecule and oligonucleotide APIs. His additional leadership experience includes working at Cambrex Corp., Altergy Systems, NextPharma and Aerojet Fine Chemicals in the areas of operations, sales and marketing, strategic planning, process optimization, and mergers and acquisitions.
   
“We are looking forward to continued growth under the leadership of Aryo Nikopour and Greg McParland,” said Assad J. Kazeminy, chief executive officer and founder of Irvine Pharmaceutical Services. “I am confident they will lead us to even greater success as we expand and work to provide ever improving services to our clients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics